JAMIA open · 2026
Advancing multi-database cohort studies: lessons learned from a studyathon in a pharmaceutical company.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Inan-Eroglu Elif, Rodriguez-Molina Daloha, Abdelgawwad Khaled, Dinkel-Keuthage Carina, Soriano Gabarró Montse, Vora Pareen, Candore Gianmario, Vizcaya David, Manlik Katrin
Аннотация
OBJECTIVES: To evaluate the feasibility and applicability of the studyathon format within a pharmaceutical company setting for generating reliable real-world evidence rapidly for a business-relevant research question.
MATERIALS AND METHODS: Conducted at Bayer, the studyathon assessed recurrent events following a first-ever transient ischemic attack. It involved an 8-week preparatory phase, a 1-week execution phase, and a 3-week post-event phase, using multiple real-world data sources.
RESULTS: The studyathon concluded successfully with a conference abstract submission. Key learnings included the importance of defining precise research questions, organizational alignment, thorough preparation, and leveraging diverse expertise and skill sets.
DISCUSSION: The studyathon format proved suited for a pharmaceutical setting and revealed insights into its application. Our learnings highlight differences from multi-stakeholder community studyathons.
CONCLUSION: The studyathon demonstrated its potential as a valuable research approach within a pharmaceutical company. It improved study timelines and cross-functional collaboration while preserving scientific rigor.
MATERIALS AND METHODS: Conducted at Bayer, the studyathon assessed recurrent events following a first-ever transient ischemic attack. It involved an 8-week preparatory phase, a 1-week execution phase, and a 3-week post-event phase, using multiple real-world data sources.
RESULTS: The studyathon concluded successfully with a conference abstract submission. Key learnings included the importance of defining precise research questions, organizational alignment, thorough preparation, and leveraging diverse expertise and skill sets.
DISCUSSION: The studyathon format proved suited for a pharmaceutical setting and revealed insights into its application. Our learnings highlight differences from multi-stakeholder community studyathons.
CONCLUSION: The studyathon demonstrated its potential as a valuable research approach within a pharmaceutical company. It improved study timelines and cross-functional collaboration while preserving scientific rigor.